In an effort to battle against what members feel is an existential threat to their business, a group of 10 domestic biotech companies have launched the Midsized Biotech Alliance of America with a ...

Anthropic CEO Dario Amodei says artificial intelligence could trigger a biotech renaissance, accelerating breakthroughs in peptide drugs, CAR-T therapies, and programmable biology through AI-assisted ...

"If the neurons fire in a specific pattern, the Doom guy shoots." The post Researchers Get Human Brain Cells Running Doom ...

Scientists have demonstrated that human brain cells grown on a microchip can learn to play id Software’s classic first-person ...

MINSK, 1 March (BelTA) – In an interview with the First News TV Channel, Head of the Belarus President Administration Dmitry ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. | Generate:Biomedicines is the latest biotech to benefit from a ...

Q4 2025 earnings call highlights Astellas deal, VIR-5500 Phase I data, runway to 2028, and pipeline outlook—read now.

The human gut microbiome has a close connection to our well-being, and it has the potential to be used as a biomarker of ...

Guidance language shifted to a more specific projection of 15%-20% operating expense growth for 2026, compared to less specific spending outlook in Q3. Management's confidence increased, underpinned ...

Earlier this month, Patrick Gruhn cut a $20,000 check to Tony DeBone’s reelection campaign for Deschutes County Commissioner. Gruhn, a tech tycoon and lawyer currently operating an international ...

If you are wondering whether uniQure's current share price reflects its true worth, you are not alone. This article walks through what the numbers are really saying about the stock. The share price is ...

Raleigh-based Slate Medicines just pulled in a hefty $130 million Series A, a war chest the startup says will fuel development of SLTE‑1009, an in‑licensed anti‑PACAP monoclonal antibody aimed at ...